XML 121 R120.htm IDEA: XBRL DOCUMENT v2.4.0.8
(Schedules of Concentration of Risk) (Details)
12 Months Ended
Sep. 26, 2014
Sep. 27, 2013
Sep. 28, 2012
Distributor Concentration Risk | Net Sales Attributable to Distributors | Cardinal Health, Inc.
     
Concentration Risk [Line Items]      
Concentration risk, percentage 18.00% 18.00% 19.00%
Distributor Concentration Risk | Net Sales Attributable to Distributors | McKesson Corporation
     
Concentration Risk [Line Items]      
Concentration risk, percentage 17.00% 15.00% 14.00%
Distributor Concentration Risk | Net Sales Attributable to Distributors | Amerisource Bergen Corporation
     
Concentration Risk [Line Items]      
Concentration risk, percentage 11.00% 9.00% 9.00%
Distributor Concentration Risk | Accounts Receivable Attributable to Distributors | Cardinal Health, Inc.
     
Concentration Risk [Line Items]      
Concentration risk, percentage 17.00% 18.00%  
Distributor Concentration Risk | Accounts Receivable Attributable to Distributors | McKesson Corporation
     
Concentration Risk [Line Items]      
Concentration risk, percentage 24.00% 22.00%  
Distributor Concentration Risk | Accounts Receivable Attributable to Distributors | Amerisource Bergen Corporation
     
Concentration Risk [Line Items]      
Concentration risk, percentage 13.00% 14.00%  
Distributor Concentration Risk | Accounts Receivable Attributable to Distributors | CuraScript, Inc.
     
Concentration Risk [Line Items]      
Concentration risk, percentage 13.00% 0.00%  
Product Concentration Risk | Net Sales Attributable to Products | Optiray
     
Concentration Risk [Line Items]      
Concentration risk, percentage 11.00% 14.00% 17.00%
Product Concentration Risk | Net Sales Attributable to Products | Acetaminophen products (API)
     
Concentration Risk [Line Items]      
Concentration risk, percentage 8.00% 10.00% 11.00%